NPR News: Eli Lilly Ends Coronavirus Antibody Treatment Trial, Other Studies Go On

Eli Lilly Ends Coronavirus Antibody Treatment Trial, Other Studies Go On
The trial studied the efficacy of bamlanivimab and remdesivir on hospitalized COVID-19 patients - the same therapies given to President Trump. But researchers say people showed no marked improvement.

Read more on NPR
Previous
Next Post »